Researchers pioneer technology that leads successful clinical trial to treat dry eye disease
October 4th 2021A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Read More
Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery
September 26th 2021Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.
Read More
The gene-based AAVCOVID vaccine employs a unique adeno-associated viral vector technology that was shown in non-clinical, nonhuman primate studies to enable protection from SARS-CoV-2 challenge and to induce sustained antibody and cellular immune responses from a single dose for up to a year.
Read More